These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21119195)

  • 121. Medical treatment for an adult patient with eisenmenger syndrome. A case report.
    Yao A
    Int Heart J; 2015; 56 Suppl():S8-11. PubMed ID: 25787798
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Imatinib is partially effective for the treatment of pulmonary capillary hemangiomatosis.
    Adachi S; Hirashiki A; Kondo T; Nakaguro M; Ogawa A; Miyaji K; Matsubara H; Yokoi T; Murohara T
    Intern Med; 2014; 53(6):603-7. PubMed ID: 24633031
    [TBL] [Abstract][Full Text] [Related]  

  • 123. "Idiopathic" pulmonary arterial hypertension in early infancy: Excluding NFU1 deficiency.
    Stéphanie P; Catherine B; Thierry S; Jean-Luc V; Isabelle L; Sara S; Christophe V; Marie-Cécile N
    Ann Pediatr Cardiol; 2019; 12(3):325-328. PubMed ID: 31516295
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Chronic thromboembolic pulmonary hypertension complicated with homocystinuria.
    Ogawa S; Katayama T; Kaikita K; Tsukamoto M; Yamamoto E; Yamamuro M; Tanaka T; Tsujita K; Kojima S; Tayama S; Hokimoto S; Yamabe H; Indo Y; Endo F; Matsubara H; Ogawa H
    Intern Med; 2014; 53(22):2605-8. PubMed ID: 25400183
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Combined use of ursodeoxycholic acid and bosentan prevents liver toxicity caused by endothelin receptor antagonist bosentan monotherapy: two case reports.
    Ito T; Ozaki Y; Son Y; Nishizawa T; Amuro H; Tanaka A; Tamaki T; Nomura S
    J Med Case Rep; 2014 Jul; 8():250. PubMed ID: 25015229
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Better off blue: BMPR-2 mutation, arteriovenous malformation, and pulmonary arterial hypertension.
    Soon E; Southwood M; Sheares K; Pepke-Zaba J; Morrell NW
    Am J Respir Crit Care Med; 2014 Jun; 189(11):1435-6. PubMed ID: 24881940
    [No Abstract]   [Full Text] [Related]  

  • 127. Efficacy of immunosuppressants with bridge vasodilator therapy in severe lupus erythematosus-associated pulmonary arterial hypertension.
    Sanges S; Savale L; Lamblin N; Rémy-Jardin M; Humbert M; Sobanski V
    ESC Heart Fail; 2019 Dec; 6(6):1322-1325. PubMed ID: 31536678
    [TBL] [Abstract][Full Text] [Related]  

  • 128. [Tunnelled central venous catheter infection during treatment with epoprostenol].
    Koszutski M; Faure M; Guillaumot A; Gomez E; Mercy M; Chabot F; Chaouat A
    Rev Mal Respir; 2018 Mar; 35(3):324-327. PubMed ID: 29602480
    [TBL] [Abstract][Full Text] [Related]  

  • 129. A case of anti-aminoacyl tRNA synthetase (ARS) antibody-positive polymyositis (PM)/dermatomyositis (DM)-associated interstitial pneumonia (IP) successfully controlled with bosentan therapy.
    Naito T; Tanaka Y; Hino M; Gemma A
    Respir Med Case Rep; 2017; 21():62-65. PubMed ID: 28393009
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Idiopathic pulmonary arterial hypertension in a young patient with the Cohen syndrome.
    Cokkinos P; Gkouziouta A; Karavolias G; Kariofillis P; Voudris V
    Hellenic J Cardiol; 2013; 54(2):143-6. PubMed ID: 23557616
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Long survival of congenital alveolar capillary dysplasia patient with NO inhalation and epoprostenol: effect of sildenafil, beraprost and bosentan.
    Kodama Y; Tao K; Ishida F; Kawakami T; Tsuchiya K; Ishida K; Takemura T; Nakazawa A; Matsuoka K; Yoda H
    Pediatr Int; 2012 Dec; 54(6):923-6. PubMed ID: 23279022
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Oral vasodilator therapy in patients with moderate to severe portopulmonary hypertension as a bridge to liver transplantation.
    Raevens S; De Pauw M; Reyntjens K; Geerts A; Verhelst X; Berrevoet F; Rogiers X; Troisi RI; Van Vlierberghe H; Colle I
    Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):495-502. PubMed ID: 23242127
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension.
    Anthi A; Tsangaris I; Hamodraka ES; Lekakis J; Armaganidis A; Orfanos SE
    Blood; 2012 Aug; 120(7):1531-2. PubMed ID: 22899478
    [No Abstract]   [Full Text] [Related]  

  • 134. Treat-to-target approach in pulmonary arterial hypertension: a consensus-based proposal.
    Sitbon O; Baloira Villar A; Bauer F; Ekmehag B; Gin-Sing W; Jansson K; Kiely DG; Leuchte H; Manes A; Rosenkranz S; Escribano P
    Eur Respir Rev; 2012 Sep; 21(125):259-62. PubMed ID: 22941892
    [No Abstract]   [Full Text] [Related]  

  • 135. Pulmonary arterial hypertension: combination therapy in the modern management era.
    Sitbon O
    Eur Respir Rev; 2010 Dec; 19(118):348-9. PubMed ID: 21119195
    [No Abstract]   [Full Text] [Related]  

  • 136. Bosentan for the treatment of portopulmonary hypertension.
    Tempe DK; Datt V; Datta D
    Ann Card Anaesth; 2008; 11(2):139-40; author reply 140. PubMed ID: 18603763
    [No Abstract]   [Full Text] [Related]  

  • 137. Bosentan and sildenafil: should the combination therapy be a valid alternative in childhood to prostacyclin infusion?
    Brancaccio G; Toscano A; Bevilacqua M; Di Chiara L; Parisi F
    Pediatr Transplant; 2007 Feb; 11(1):110-2. PubMed ID: 17239133
    [TBL] [Abstract][Full Text] [Related]  

  • 138. [Bosentan and chronic thromboembolic pulmonary hypertension].
    Tomás C; Callejas-Rubio JL; Ríos-Fernández R; Ortego-Centeno N
    Med Clin (Barc); 2007 Nov; 129(16):639. PubMed ID: 18001681
    [No Abstract]   [Full Text] [Related]  

  • 139. Combination drug therapy in the management of pulmonary arterial hypertension.
    Kayser SR
    Prog Cardiovasc Nurs; 2005; 20(4):177-82. PubMed ID: 16276142
    [No Abstract]   [Full Text] [Related]  

  • 140. Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation.
    Chen YF; Jowett S; Barton P; Malottki K; Hyde C; Gibbs JS; Pepke-Zaba J; Fry-Smith A; Roberts J; Moore D
    Health Technol Assess; 2009 Oct; 13(49):1-320. PubMed ID: 19863849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.